MSN Asks Federal Circuit to Revive Entresto Patent Delisting Bid

MSN Laboratories Pvt. Ltd. is appealing rulings that block the early launch of its copy of Entresto and preserve Novartis AG’s market exclusivity for the blockbuster heart-disease drug until a patent’s pediatric exclusivity expires in July.

MSN is asking the Federal Circuit to overturn Judge Richard G. Andrews’ April 1 final judgment and his April 29 denial of its post-trial motions, including a request to vacate the judgment and remove Novartis’ US Patent No. 8,101,659 from the FDA’s Orange Book, according to a notice filed Wednesday in the US District Court for the District of Delaware.

Andrews, ruling from the bench ...